Arachidonyl-2â²-chloroethylamide (ACEA), a synthetic agonist of cannabinoid receptor, increases CB1R gene expression and reduces dyskinesias in a rat model of Parkinson's disease
Leija-Salazar, Melissa, Bermúdez de León, Mario, González-Horta, Azucena, González-Hernández, BrendaVolume:
194
Journal:
Pharmacology Biochemistry and Behavior
DOI:
10.1016/j.pbb.2020.172950
Date:
July, 2020
File:
PDF, 633 KB
2020